Sunesis Pharmaceuticals Inc. appointed H. Ward Wolff as a board member.
Wolff was most recently executive vice president and CFO of Sangamo Therapeutics Inc., serving at the company from December 2007 until his retirement in March 2017.
Sunesis Pharmaceuticals appoints director
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
Sunesis Pharmaceuticals Inc. appointed H. Ward Wolff as a board member.
Wolff was most recently executive vice president and CFO of Sangamo Therapeutics Inc., serving at the company from December 2007 until his retirement in March 2017.